![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
AstraZeneca partners with peers and academia to establish translational research fund
AstraZeneca together with GlaxoSmithKline and Johnson & Johnson has partnered with three world-class universities, Imperial...
UMMS study shows Google Glass effective tool for toxicology consult in ER
Researchers at UMass Medical School have found that Google Glass, a head-mounted streaming audio/video device,...
Working Towards a Healthier Future
About one to two of every 1000 babies are born with hydrocephalus, a condition in...
ASCO hail cancer immunotherapy as clinical cancer advance of the year
In their just-released Clinical Cancer Advances 2016: ASCO’s Annual Report on Progress Against Cancer the...
Study Finds High Proportion of Advanced Breast Cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large...
Cancer Remains Leading Cause of Death in U.S. Hispanics
While cancer is the second leading cause of death overall in the United States, it...
Landmark study confirms complexity and informs the next stages of research
The largest population genome sequencing effort to date is published today in Nature. A series...
Amgen and Kite Pharma to develop CAR T cell immunotherapies
US-based Amgen has signed a strategic research collaboration and license agreement with Kite Pharma to...
TxCell and Ferring partner with Trizell to further develop Ovasave to treat IBD
France-based TxCell and Switzerland's Ferring International have partnered with Trizell Holding to further enhance the...
Novartis, Intellia and Caribou to develop new medicines and drug discovery tools
Swiss drug-maker Novartis has entered collaboration and licensing agreements with Intellia Therapeutics to develop new...